Company / Net Income
ATOSSA THERAPEUTICS, INC. Net Income History
FY2012-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$15.8M
FY2016
5-year range
-$15.8M / -$122.9K
FY2012-FY2016
Trend
-7.5%
vs FY2015
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Net Income has declined for 3 consecutive years, from -$122,857 in FY2013 to -$16M in FY2016.
Based on SEC 10-K filings.
-$16M in FY2016.
Declined from -$11M to -$16M over the past 2 years.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- ATOSSA THERAPEUTICS, INC.'s net income has declined for 3 consecutive years.
- In FY2016, net income decreased 7.5% year-over-year.
- Peak net income was recorded in FY2013.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -15.14 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2016 | -$15.8M | -7.5% |
| FY2015 | -$14.7M | -35.9% |
| FY2014 | -$10.8M | -8678.3% |
| FY2013 | -$122.9K | +0.0% |
| FY2012 | -$122.9K | - |
As of FY2016 · SEC 10-K · Updated Jun 24, 2026